IMiA 2023 program will be two and a half day program, showcasing international and local professionals. Throughout the program common themes will be intertwined.
Lessons learnt and unlearnt
Global to local
Vulnerability and resilience
The future of innovation




- Friday, 17 Feb 2023
- Saturday, 18 Feb 2023
- Sunday, 19 Feb 2023
0715-1800
Registration open
0730-0830
INDUSTRY BREAKFAST SYMPOSIA
Treatment Transitions: managing changes in opioid treatment
This symposium will explore treatment transitions in both community and correctional settings. Dr Jillian Roberts, the Clinical Director of the NSW Justice Health & Forensic Mental Health Network will outline the learning from the large-scale uptake of long-acting injectable buprenorphine (LAIB) in NSW correctional settings that has occurred over the past 3 years. Dr Victoria Hayes, Staff Specialist in the SESLHD Drug & Alcohol Services, will present some of the early data from a LAIB discontinuation study, providing insights into patient outcomes and the supportive care is required.
Dr Jillian Roberts
Clinical Director, NSW Justice Health & Forensic Mental Health Network
Dr Vicky Hayes
Staff Specialist, SESLHD Drug & Alcohol Services
Proudly hosted by

Must register to attend. places are limited.
0845-0915
Opening
0915-1015
KEYNOTE ADDRESS
Conciliating access, quality care and acceptability of opioid use disorder treatment in the midst of opioid and Covid epidemics: the Canadian experience
Canada Research Chair in Addiction Medicine; Professor in the Department of Family and Emergency Medicine at Université de Montréal
1015-1045
PLENARY
Long acting depot buprenorphine in Australia: implementation, clinical and research challenges
Director and Senior Staff Specialist, Drug and Alcohol Services, South East Sydney Local Health District (SESLHD), NSW Health; Conjoint Professor, Discipline of Addiction Medicine, Faculty Medicine and Health, University of Sydney
1045-1115
Morning tea
1115-1200
PANEL
Managed alcohol programs: where are we and where to now in Australia
Scientist, Canadian Institute for Substance Use Research; Professor Emeritus and Adjunct Professor, Department of Psychology, University of Victoria
Canadian Institute for Substance Use Research, School of Nursing, University of Victori
Clinical Director, Alcohol and Drug Service St Vincent's Hospital Sydney Australia; Director, National Centre for Clinical Research on Emerging Drugs
Director, Aboriginal & Torres Strait Islander Health Service NSLHD; Adjunct Associate Professor, National Drug & Alcohol Research Centre, UNSW Medicine
1200-1230
PLENARY
Early Intervention and Treatment for Substance Use Disorders in Young People: Missteps, Opportunities and Windows for Change
Head, Substance Use Research, Orygen; Principal Research Fellow, Centre for Youth Mental Health, The University of Melbourne
1230-1300
PLENARY
The impact of alcohol on physical morbidity and mortality in Australia
Director, Alcohol and Drug assessment Unit, Princess Alexandra Hospital
1300-1400
Lunch
1300-1330
The Royal Australian College of General Practitioners (RACGP) member meeting

1400-1530
CONCURRENT WORKSHOPS / SYMPOSIUMS
Novel approaches to managing opioid dependence
Canada Research Chair in Addiction Medicine; Professor in the Department of Family and Emergency Medicine, Université de Montréal
Director and Senior Staff Specialist, Drug and Alcohol Services, South East Sydney Local Health District (SESLHD), NSW Health; Conjoint Professor, Discipline of Addiction Medicine, Faculty Medicine and Health, University of Sydney
Clinical Director, Alcohol and Drug Service St Vincent’s Hospital Sydney Australia; Director, National Centre for Clinical Research on Emerging Drugs
What we did in the shadows (of COVID-19): Trainee showcase
Identifying, and treating gambling problems: A practical guide to understanding and responding to harms
Director at Gambling Treatment & Research Clinic & Professor of Psychology, University of Sydney
Senior Clinical Supervisor, GambleAware Greater Sydney, University of Sydney
Innovative treatment approaches for young people
Head, Substance Use Research, Orygen
Orygen; Department of Psychiatry, The University of Melbourne; Turning Point, Eastern Health
Novel approaches to managing opioid dependence
Dr Julie Bruneau
Canada Research Chair in Addiction Medicine; Professor in the Department of Family and Emergency Medicine, Université de Montréal
Professor Nick Lintzeris
Director and Senior Staff Specialist, Drug and Alcohol Services, South East Sydney Local Health District (SESLHD), NSW Health; Conjoint Professor, Discipline of Addiction Medicine, Faculty Medicine and Health, University of Sydney
Dr Nadine Ezard
Clinical Director, Alcohol and Drug Service St Vincent’s Hospital Sydney Australia; Director, National Centre for Clinical Research on Emerging Drugs
Professor Adrian Dunlop
Director, Drug & Alcohol Clinical Services, Hunter New England Health
Identifying, and treating gambling problems: A practical guide to understanding and responding to harms
Professor Sally Gainsbury
Director at Gambling Treatment & Research Clinic & Professor of Psychology, University of Sydney
Dr Christopher Hunt
Senior Clinical Supervisor, GambleAware Greater Sydney, University of Sydney
Innovative treatment approaches for young people
Associate Professor Gill Bedi
Head, Substance Use Research, Orygen
Dr Edward Mullen
Orygen; Department of Psychiatry, The University of Melbourne; Turning Point, Eastern Health
Associate Professor Yvonne Bronmo
Director, St Vincent’s Hospital; Department of Addiction Medicine, University Of Melbourne
What we did in the shadows (of COVID-19): Trainee showcase
- Admission to Detox Unit via the ‘Take A Break’ Program
Dr Rebecca Lee
AOD Advanced Trainee, NT Department of Health - GHB Use Trends and Clinical Challenges
Dr Manu Bhatnagar
Addiction Psychiatry Trainee, Turning Point
- A complex case of comorbidities
Dr Bianca Davidde
Addiction Medicine Registrar, Drug And Alcohol Services SA
1530-1600
Afternoon tea
1600-1730
CONCURRENT WORKSHOPS / SYMPOSIUMS
Peer support and consumer perspectives in opioid pharmacotherapy
Baden Hicks
Sarah Lord
Sione Crawford
CEO, Harm Reduction Victoria
Cannabinoids as therapeutics: are we there yet?
Professor of Psychopharmacology, University College London (UCL)
Dr Michael Aufgang
Fitness to drive assessments
Professor Ed Ogden
Addiction Medicine Specialist, Goulburn Valley Health
Rebecca L. Cooper Al & Val Rosenstrauss Fellow, Swinburne University Of Technology
Centre for Human Psychopharmacology, Swinburne University of Technology
Innovative treatment approaches for young people
Head, Substance Use Research, Orygen
Orygen; Department of Psychiatry, The University of Melbourne; Turning Point, Eastern Health
Fitness to drive assessments
Professor Ed Ogden
Addiction Medicine Specialist, Goulburn Valley Health
Dr Amie Hayley
Rebecca L. Cooper Al & Val Rosenstrauss Fellow, Swinburne University Of Technology
Professor Luke Downey
Centre for Human Psychopharmacology, Swinburne University of Technology
Cannabinoids as therapeutics: are we there yet?
Professor Val Curran
Professor of Psychopharmacology, University College London (UCL)
Dr Michael Aufgang
GP, Meadows Medical Centre
Innovative treatment approaches for young people
Associate Professor Gill Bedi
Head, Substance Use Research, Orygen
Dr Edward Mullen
Orygen; Department of Psychiatry, The University of Melbourne; Turning Point, Eastern Health
Associate Professor Yvonne Bonomo
Director, St Vincent’s Hospital; Department of Addiction Medicine, University Of Melbourne
Peer support and consumer perspectives in opioid pharmacotherapy
Baden Hicks
Pharmacotherapy Peer Support worker, Turning Point
Sarah Lord
Program Manager, The PAMS Service, Harm Reduction Victoria
Sione Crawford
CEO, Harm Reduction Victoria
1730-1900
SOCIAL EVENT
Welcome Reception
Join colleagues and friends for a warm welcome to Melbourne and IMiA 2023. The Welcome Reception is included in full registrations. Additional persons are welcome at a cost of $88 per person. Register extra persons now
Proudly sponsored by
0715-1730
Registration open
0730-0830
INDUSTRY BREAKFAST SYMPOSIA
Driving towards HCV elimination: Hepatitis C and patients with comorbid drug & alcohol and mental health conditions
This event will focus on understanding the needs of patients with comorbid drug & alcohol and mental health conditions and Hepatitis C. HCPs will:
- Gain a deeper understanding of the needs of these patients to help accelerate progress to HCV elimination in this specialist population.
- Learn practical tips on how to incorporate HCV management alongside treatment of drug & alcohol and mental health conditions.
- Become familiar with strategies to engage the hard-to-reach patients and ensure connection and linkage to care to optimize patient outcomes.
Dr Ferghal Armstrong
Addiction Medicine Staff Specialist, Turning Point
Jason Harrison
Nurse Practitioner, Alcohol & Other Drugs Service, Rockhampton
Proudly hosted by

Places are limited, you must register to attend.
0900-1000
KEYNOTE ADDRESS
Defining the next decade of treatments for traumatic stress and addiction
Vice Provost for Research, Chancellor-Provost’s Office, Rutgers-New Brunswick; Center Director and Helen E. Chaney Endowed Chair in Alcohol Studies
1000-1030
PLENARY
Caughey Lecture: Are we there yet, and how do we get to where we want to go?
Conjoint Professor, The Kirby Institute, UNSW Sydney; Chair, The National Centre for Clinical Research on Emerging Drugs (NCCRED)
1030-1100
Morning tea
1100-1130
PLENARY
The value of lived experience in alcohol advocacy
Founder and CEO, Sober in the Country
1130-1200
PLENARY
Challenging Australia's current approach to addiction
Executive Clinical Director, Turning Point, Eastern Health; Professor of Addiction Studies and Services, Eastern Health Clinical School; Director, Monash Addiction Research Centre, Monash University; Professorial Fellow, NHMRC
1200-1300
PANEL
Practitioner health wellbeing
Professor of Law and Public Health, University of Melbourne
Social Foundations of Medicine, Medical School, Australian National University
1300-1400
Lunch
1300-1330
The Royal Australasian College of Physicians (RACP) member meeting

The Royal Australian and New Zealand College of Psychiatrists (RANZCP) member meeting

1400-1530
CONCURRENT WORKSHOPS / SYMPOSIUMS
Real time prescription monitoring
Professor Suzanne Nielsen
Deputy Director, Monash Addiction Research Centre, Monash University
Dr Hester Wilson
Drug and Alcohol Services, Population and Community Health, South East Sydney Local Health District; School of Population Health, University of New South Wales; Centre for Primary Health Care and Equity (CPHCE), University of New South Wales; Mental Health and Drug and Alcohol, Murrumbidgee Local Health district; Chair of SIF Addiction, RACGP
Dr Louisa Picco
Research Fellow, Monash University
There’s an app for that! The which, when, why and how on smartphone apps targeting addictive behaviours
Associate Professor Victoria Manning
Associate Professor of Addiction Studies, Monash University; Head of Research and Workforce Development, Turning Point, Eastern Health
Associate Professor Petra Staiger
Associate Professor in the School of Psychology and Deputy Director of the Centre for Drug Use, Addictive and Anti-social behaviour (CEDAAR), Deakin University
Trauma treatments: from research to practice
Dr Denise Hien
Vice Provost for Research, Chancellor-Provost’s Office, Rutgers-New Brunswick; Center Director and Helen E. Chaney Endowed Chair in Alcohol Studies
Professor Katherine Mills
The Matilda Centre for Research In Mental Health and Substance Use, University Of Sydney
Associate Professor Shalini Arunogiri
Clinical Director, Turning Point; NHMRC Research Fellow, Monash University
Ready player one: Treating gaming disorder
Dr Ben Riley
Senior clinician, Flinders Psychological Therapy Service Southern Adelaide Local Health Network; College of Medicine and Public Health, Flinders University
1530-1600
Afternoon tea
1600-1730
CONCURRENT WORKSHOPS / SYMPOSIUMS
Asia Pacific forum: sharing practice across our region
Dr Roshan Bhad
Associate Professor of Psychiatry & National Drug Dependence Treatment Centre, AIIMS, New Delhi, India; Chairperson, ISAM NExT & Ex Officio Board of Director, International Society of Addiction Medicine (ISAM)
Dr Atul Ambekar
Professor, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi; Secretary General, Addiction Psychiatry Society of India (APSI)
Dr David Jacka
Addiction Medicine Specialist, Monash Health
Anja Busse
Programme Officer, United Nations Office on Drugs and Crime
Nico Clark
Advocacy in addiction
Professor Dan Lubman
Director, Turning Point, Eastern Health; Professor of Addiction Studies and Services, Eastern Health Clinical School; Director, Monash Addiction Research Centre, Monash University; Professorial Fellow, NHMRC
Caterina Giorgi
Chief Executive Officer, Foundation for Alcohol Research and Education
Practitioner Health and Wellbeing: supporting ourselves and each other
Professor of Law and Public Health, University of Melbourne
Associate Professor Louise Stone
Social Foundations of Medicine, Medical School, Australian National University
Dr Paul Grinzi
General Practitioner, RACGP, Royal Park Medical
Performance and image enhancing drugs addiction
Dr Beng Eu
GP and Co-director, Prahran Market Clinic
Dr Kevin Lee
Endocrinologist, Monash University
Dr Marcus Squirrell
Clinical Psychologist, Richmond Central Psychology
1830-2230
SOCIAL EVENT
Gala Dinner
Join us at Cargo Hall, for a great night of entertainment and three course meal. Limited tickets are available, secure your place via the registration page.
Attire: Business casual
0830
Registration open
0900-1000
KEYNOTE ADDRESS
Cannabinoids in the development of cannabis addiction and their potential in its treatment
Emeritus Professor of Psychopharmacology, University College London (UCL)
1000-1100
PLENARY
Gambling, gaming, divergence and convergence
Department of Psychiatry, Flinders Medical Centre & College of Medicine and Public Health, Flinders University; Head, Flinders Psychological Therapy Services (Centre for Anxiety and Related Disorders, & IAPT@flinders, Statewide Gambling Therapy Services); Senior Specialist, Drug and Alcohol Services South Australia
1100-1130
Morning tea
1130-1230
PLENARY
No one left behind: addressing tobacco use in drug and alcohol treatment settings
Professor and Lead of Public Health, College of Medicine & Public Health, Flinders University
1230-1315
PANEL
Psychedelic assisted psychotherapy for addiction: tripping over ourselves in our readiness?
Dr Paul Liknaitzky
Head, Clinical Psychedelic Research, Monash University
Head, Substance Use Research, Orygen; Principal Research Fellow, Centre for Youth Mental Health, The University of Melbourne
Clinical Psycologist, St Vincent's Hospital Sydney; University of New South Wales
1315-1330